Interferon for pancreatic cancer

M Levin, MD — Fri, 24 Aug 2012 19:35:04 +0000

Interferon is known to have anti-proliferative effects against pancreatic cancer cells and mesothelioma. Unfortunately, clinical evidence for effectiveness is lacking. Most available studies had been in adjuvant settings where the drug’s anti-angiogenic(blood vessel formation) properties may be most prominent. A few metastatic studies do not demonstrate a marked benefit of adding interferon to chemotherapy.

NeoPlas Innovation’s Stephen Cantrell, M.D., has opened a clinic where he uses lovastatin with interferon for a variety of cancer diagnosis. We await peer-reviewed publications on the results of this approach.

Read the Professional version here.

ALCAT Testing

M Levin, MD — Tue, 19 Jun 2012 17:38:43 +0000

The antigen leukocyte cellular antibody test (ALCAT) is a proprietary test created and promoted by American Medical Testing Laboratories and Cell Science Systems, of Deerfield Beach, Florida. It markets this test as a screening test for adverse reactions to specific foods, food additives, food colorings and other chemicals. The test has been reformulated several times. It is generally considered to be an unproven test. “These results have been shown to not be reproducible, give different results when duplicate samples are analyzed blindly, don’t correlate with those from conventional testing, and ‘diagnose’ food hypersensitivity in subjects with conditions where food allergy is not considered to play a pathogenic role.” A recent supportive study is also open to being characterized in this way.

Read the Professional version here.

Cancer Treatment Today » Allergy and Immunology

Interferon for pancreatic cancer

ALCAT Testing